MALLINCKRODT - CMDS BUSINESS
MALLINCKRODT - CMDS BUSINESS
Industry:
Advertising Information Technology Marketing Staffing Agency
Founded:
1867-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Status:
Active
Similar Organizations
Homesync
Homesync provides tools for the easiest social media management system.
Infinity Incentive Group
Helping other achieve higher ROI by using our loyalty based reward incentive products
Media Staffing
Media Staffing is a boutique firm with a business consulting approach to digital media recruiting.
Visionstar
Visionstar creates business technology infrastructure, online marketing and telephone sales for assorted companies.
More informations about "Mallinckrodt - CMDS business"
Mallinckrodt - CMDS business - Crunchbase Company Profile
Mallinckrodt - CMDS business is located in St Louis, Missouri, United States. Who are Mallinckrodt - CMDS business 's competitors? Alternatives and possible competitors to …See details»
News Detail | Mallinckrodt Pharmaceuticals
For the first six months of fiscal 2015, sales of Mallinckrodt's CMDS business were $210 1 million. Starting in the fourth quarter of fiscal 2015, the company will report the CMDS business as a …See details»
Guerbet completes acquisition of Mallinckrodt's Contrast
Nov 27, 2015 · Guerbet is acquiring 100% of the Mallinckrodt CMDS business for $270M total, paid in cash and financed by a loan syndicated by BNP Paribas. Acquisition creates a global …See details»
Mallinckrodt (CMDS Business) - PitchBook
Information on acquisition, funding, investors, and executives for Mallinckrodt (CMDS Business). Use the PitchBook Platform to explore the full profile.See details»
Mallinckrodt Completes Sale Of Its Contrast Media And Delivery …
Nov 27, 2015 · Mallinckrodt's action to divest its CMDS business follows through on the company's stated objective to become a high-growth specialty pharmaceutical business, …See details»
News Detail | Mallinckrodt Pharmaceuticals
Mallinckrodt's action to divest its CMDS business follows through on the company's stated objective to become a high-growth specialty pharmaceutical business, transforming its …See details»
GUERBET : completes acquisition of Mallinckrodt's Contrast Media …
Nov 27, 2015 · Guerbet is acquiring 100% of the Mallinckrodt CMDS business for $270M total, paid in cash and financed by a loan syndicated by BNP Paribas. Acquisition creates a global …See details»
RSNA 2015: Guerbet Announces Mallinckrodt Contrast Media and …
5 days ago · Guerbet acquired 100% of the Mallinckrodt CMDS business for $270M total, paid in cash and financed by a loan syndicated by BNP Paribas.See details»
Gide, counsel to Guerbet on the acquisition of Mallinckrodt’s …
Gide advises Guerbet, a pioneer in the field of contrast agents for medical imaging, on the acquisition of US leading specialty biopharmaceutical company Mallinckrodt’s Contrast Media …See details»
GUERBET : Mallinckrodt Completes Sale Of Its Contrast Media And ...
Nov 27, 2015 · Mallinckrodt's action to divest its CMDS business follows through on the company's stated objective to become a high-growth specialty pharmaceutical business, …See details»
Mallinckrodt - CMDS business - Crunchbase
Mallinckrodt - CMDS business contrast media and delivery systemsSee details»
Mallinckrodt plc Reports Strong Fourth Quarter and 2019 Results
Trudeau continued, "Over the past year, it has been one of our top priorities to remove three uncertainties impacting our business - opioid litigation, near-term debt maturities and the …See details»
Guerbet acquires Mallinckrodt - CMDS business - Crunchbase
Mallinckrodt - CMDS business Mallinckrodt - CMDS business contrast media and delivery systems Acquiring Organization: Guerbet Guebert is a pharmaceutical company based in …See details»
Mallinckrodt Completes Sale of Contrast Media and Delivery …
Nov 30, 2015 · Mallinckrodt announced that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 …See details»
Mallinckrodt - Wikipedia
Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. …See details»
Mallinckrodt plc Reports Strong Fourth Quarter and Total …
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the three months and fiscal year ended Dec. 28, 2018.See details»
Mallinckrodt Enters Agreement To Sell Its Contrast Media And …
Jul 27, 2015 · CHESTERFIELD, United Kingdom, July 27, 2015 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty biopharmaceutical company, announced today that it has …See details»
Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical …
As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.See details»
Mallinckrodt Pharmaceuticals - Listening for Needs. Delivering …
Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products. Areas of focus include therapeutic drugs for …See details»
Mallinckrodt Emerges from Chapter 11 with ... - Markets Insider
DUBLIN, Ireland, June 16, 2022 /PRNewswire/ -- Mallinckrodt plc (" Mallinckrodt " or the "Company") today announced that it has successfully completed its reorganization process, …See details»